Serum lipoproteins after treatment with verapamil for 6 months.
Fasting levels of serum lipids and lipoproteins were measured in survivors of acute myocardial infarction after 6 months of treatment with placebo (n = 19) or verapamil 360 mg daily (n = 13). There were no significant differences between the groups and values had not changed in the verapamil group 2 weeks after cessation of treatment.
D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy; D014280:Triglycerides / Q000097:blood; D014700:Verapamil / Q000494:pharmacology* / Q000627:therapeutic use
D008074:Lipoproteins; D014280:Triglycerides; D002784:Cholesterol; D014700:Verapamil